Global Burden And Trends of Lung Cancer Incidence And Mortality

Author:

Li Chao1,Lei Shaoyuan2,Ding Li1,Xu Yan1,Wu Xiaonan1,Wang Hui1,Zhang Zijin1,Gao Ting2,Zhang Yongqiang1,Li Lin1

Affiliation:

1. Beijing Hospital

2. National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital

Abstract

Abstract Objective: Lung cancer is the leading cause of cancer-related deaths around the world for many years. The aim of this study is to investigate the global patterns and trends of lung cancer, and expects to promote health education and sustainable cancer prevention measures.Methods: Lung cancer incidence and mortality were derived from GLOBOCAN 2020 database. Continued data from Cancer Incidence in Five Continents Time Trends was used to analyze the temporal trends from 2000 to 2012 by using Joinpoint regression, and annual average percent changes were calculated. The association between Human Development Index and lung cancer incidence and mortality were assessed by linear regression.Results: An estimated 2.2 million new lung cancer cases and almost 1.8 million lung cancer deaths occurred in 2020. The age-standardized incidence ranged from 36.8 per 100 000 in Demark from 5.9 per 100 000 in Mexico. The age-standardized mortality rates varied from 32.8 in Poland to 4.9 in Mexico. Both the age-standardized incidence and mortality rates were about 2 times higher in men than in women. The ASIR of lung cancer were downward trend in United States of America (USA) between 2000 and 2012, which was more prominent in males. The age-specific incidence rates of male and female lung cancer in the age group of 50-59 years were upward trend in China. Conclusions: The burden of lung cancer is still not optimistic, especially in developing countries like China. Taking into consideration the effectiveness of tobacco control and screening in developed countries, such as USA, we need to further strengthen health education, accelerate the establishment of tobacco control policies and regulations, and improve the early cancer screening awareness to curb the future lung cancer burden.

Publisher

Research Square Platform LLC

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3